The National Shipping Co. of Saudi Arabia (Bahri) is likely to post SAR 172 million net profit for Q3-2015; more than double its profit for the year-ago period, Maceen Capital said in its earnings preview of a number of Tadawul-listed companies under its coverage.
Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) , the kingdom’s largest pharmaceutical producer, is seen to report a 39 percent profit increase to SAR 51 million in Q3.
Petro Rabigh is expected to post a net profit of SAR 434 million in third quarter, an increase of 48 percent year-on-year (YOY), Maceen Capital added.
Meanwhile, SIIG is a big decliner, with a projected 48 percent drop compared to the same period during the previous year, the report added.
Maceen Capital Estimates – Q3-2015 (SAR mln) |
||
Company |
Q3-2015 estimations |
YOY change |
Al Hammadi |
37 |
+47% |
SPIMACO |
51 |
+39% |
Care |
28 |
+36% |
SADAFCO |
49 |
+3% |
Catering |
174 |
+12% |
SAPTCO |
42 |
+75% |
SGS |
164 |
-- |
Bahri |
172 |
+102% |
Petro Rabigh |
434 |
+48% |
Saudi Kayan |
(9) |
-- |
SIIG |
194 |
(48%) |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}